South Africa’s B.1.135 Variant

South Africa’s B.1.135 Variant

A new variant of the coronavirus called B.1.135, identified in South Africa may be less susceptible to the COVID-19 vaccine and may be able to reinfect those who have already had COVID-19. — Send in a voice message:...
South Africa’s B.1.135 Variant

Bamlanivimab Prophylaxis

Using a synthetic monoclonal antibody (Bamlanivimab) may be a good treatment for people in eminent danger of onset of COVID-19 before getting the vaccine. — Send in a voice message: https://podcasters.spotify.com/pod/show/covidupdates/message
South Africa’s B.1.135 Variant

COVID Autoimmunity

Current research is looking into auto antibodies as a possible cause of severe COVID-19 disease and long Covid. Research is currently being performed to see if patient suffering from these will benefit from anti-rheumatologic drugs now used to treat rheumatoid...
South Africa’s B.1.135 Variant

Does vitamin D Help in Covid?

Patients deficient in vitamin D have been found to have worse outcomes in COVID-19. There currently is not strong evidence that vitamin D supplementation helps people who do not have an underlying vitamin D deficiency. — Send in a voice message:...
South Africa’s B.1.135 Variant

Long COVID Treatment

Unfortunately we do not have evidence of effective treatment for Long Covid symptoms, the symptoms that continue long after the presumed end of infection with COVID-19. — Send in a voice message:...